KPRX

Kiora Pharmaceuticals, Inc. - Common Stock (KPRX)

About Kiora Pharmaceuticals, Inc. - Common Stock (KPRX)

Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.

Details

Daily high

$2.85

Daily low

$2.63

Price at open

52 Week High

$2.95

52 Week Low

$1.76

Market cap

12.2M

Dividend yield

Volume

119

Avg. volume

15,956

P/E ratio

-1.04

Kiora Pharmaceuticals, Inc. - Common Stock News